CAMURUS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 550.5 SEK | -1.70% |
|
-2.91% | +2.32% |
| 01:18pm | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
| May. 08 | Transcript : Camurus AB, Q1 2024 Earnings Call, May 08, 2024 |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CAMX Stock
- Revisions Camurus AB
